NCT02683629View on ClinicalTrials.gov

Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

May 2, 2019

Conditions
Parkinson's Disease
Interventions
BIOLOGICAL

NTCELL Implantation

NTCELL Implantation

OTHER

Sham Surgery

Sham Surgery

Trial Locations (1)

Unknown

Auckland City Hospital, Auckland

Sponsors
All Listed Sponsors
collaborator

Statistecol Consultants Limited

UNKNOWN

lead

Living Cell Technologies

INDUSTRY